- €277.90m
- €169.14m
- €354.35m
- 80
- 45
- 32
- 51
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 258 | 271 | 321 | 332 | 354 |
Cost of Revenue | |||||
Gross Profit | 87.9 | 89.4 | 106 | 114 | 119 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 243 | 255 | 298 | 310 | 336 |
Operating Profit | 15.1 | 15.2 | 22.2 | 22.1 | 18.4 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 15.4 | 14.7 | 22.2 | 21.4 | 20.9 |
Provision for Income Taxes | |||||
Net Income After Taxes | 11.3 | 10.7 | 15.7 | 15.1 | 14.8 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 11 | 10.5 | 15.7 | 14.7 | 14.3 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 11 | 10.5 | 15.7 | 14.7 | 14.3 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.717 | 0.711 | 1.08 | 1.02 | 0.977 |
Dividends per Share | |||||
Special Dividends per Share |